Trials / Sponsors / Revive Therapeutics, Ltd.
Revive Therapeutics, Ltd.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Bucillamine in Treatment of Patients With COVID-19 Covid19 | Phase 3 | 2020-11-27 |
| Unknown | Bucillamine Phase 2 Trial in Patients With Cystinuria Cystinuria | Phase 2 | 2017-05-01 |
| Completed | Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout Gout | Phase 2 | 2015-04-01 |